EUVIMEDEUVIMED entdecken
Kommentar

Clarifying response thresholds and regional reporting in metabolic dysfunction-associated steatotic liver disease cost-effectiveness: Letter to the Editor on “Evaluating treatment response thresholds for cost-effective treatment in metabolic dysfunction-associated steatotic liver disease”

Jice Wang

Clinical and Molecular Hepatology · 30.10.2026

DOI: 10.3350/cmh.2026.0229 ↗

Kurz gefasst

Kommentar in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 30.10.2026. Verfasst von Jice Wang. Beteiligte Einrichtung: Department of Laboratory Medicine, Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University, Luzhou, Sichuan, China. lzmcwan…. Die Arbeit nennt 1 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Cost-effectiveness analysisMetabolic dysfunction-associated steatotic liver diseaseTreatment outcome

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University, Luzhou, Sichuan, China. lzmcwangjice@126.com.

Zitieren

APA

Wang, J. (2026). Clarifying response thresholds and regional reporting in metabolic dysfunction-associated steatotic liver disease cost-effectiveness: Letter to the Editor on “Evaluating treatment response thresholds for cost-effective treatment in metabolic dysfunction-associated steatotic liver disease”. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0229

Vancouver

Wang J. Clarifying response thresholds and regional reporting in metabolic dysfunction-associated steatotic liver disease cost-effectiveness: Letter to the Editor on “Evaluating treatment response thresholds for cost-effective treatment in metabolic dysfunction-associated steatotic liver disease”. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0229

BibTeX
@article{Wang2026,
  author = {Wang, Jice},
  title = {Clarifying response thresholds and regional reporting in metabolic dysfunction-associated steatotic liver disease cost-effectiveness: Letter to the Editor on “Evaluating treatment response thresholds for cost-effective treatment in metabolic dysfunction-associated steatotic liver disease”},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  doi = {10.3350/cmh.2026.0229}
}
Kostenlos starten →